Stock screenerAll disclosures → EDGAR →
DBVT
Conviction 42HealthcareScan · Thu, Jun 25, 2026DBVT$15.94+2.18%
ResistanceSupportVol 14Vol MA14 374.58K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price15.94
Change+2.18%
Gap+6.03%
Rel volume3.51×
Avg volume335.15K
Avg $ vol5.63M
SMA 2016.95
SMA 5018.64
SMA 20017.74
Price vs 50-14.47%
Price vs 200-10.16%
MA stackmixed
50/200 cross—
Supertrenddown · 18.58
RSI (14)39
MACD hist-0.02
MACD crossbear · 4d
Stoch %K / %D19 / 17
ADX (14)18
+DI / −DI20 / 25
RSI divergenceBullish
MACD divergenceBullish
ATR %+6.30%
ADR %5.58%
52w high24.54
52w low8.51
From 52w high-35.04%
Above 52w low+87.31%
New 52w highNo
SqueezeOff
Bollinger width27.35%
%B0.28
Donchian pos13.23%
Donchian high19.81
Donchian low15.35
AVWAP (52w high)20.38
vs AVWAP high-21.79%
AVWAP (52w low)18.73
vs AVWAP low-14.89%
OBV trendUp
Chaikin MF (20)-0.13
Today vs 20d3.51×
Avg vol (14d)374.57K
Avg vol (20d)335.15K
Avg $ vol (20d)5.63M
Market cap4.72B
RS 3m (vs SPY)-32.46%
RS 6m (vs SPY)-39.19%
RS line new highNo
Trend template3/8
Technical rank21.7
1 week-2.09%
1 month-12.22%
3 months-21.36%
6 months-21.36%
1 year+87.09%
YTD-16.33%
P/E-32.11
P/B22.70
P/S837.28
P/FCF-38.77
EPS-1.05
Div yield—
ROE-70.68%
ROA-55.16%
Debt/Eq0.01
Current4.76
EV/EBITDA-31.17
Gross margin—
Net margin—
Rev growth35.77%
EPS growth-28.99%
Price target40.97
Target upside157.03%
Analyst ratingBuy
Institutional34.88%
Ent. value4.49B
Revenue900K
Net income-47.6M
Gross profit—
Free cash flow-121.71M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out59.21M
Employees161
ListedWed, Oct 22, 2014
Free float15.74M
Float %5.3%
Short interest1.67M
Days to cover5.9d
Short volume27.1%
Squeeze score61 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.12 · 1 est
Last EPS vs est−$0.56 vs −$0.14
Last surprise-300.0% miss
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank21.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.92
Support15.51
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DBVT
No recent disclosed trades by Congress in DBVT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DBVT
No recent insider (Form 4) filings in DBVT. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in DBVT · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.